|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$162,038,028 |
|
|
Indirect Value
|
$374,282,250 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
6
|
0
|
Stock
price went down : |
8
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
46.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
705,379 |
19,711 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,196,077) |
0 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-05-31 |
4 |
A |
$24.35 |
$999,989 |
I/I |
39,360 |
4,896,818 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2016-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
782,184 |
21,858 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2016-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,326,320) |
0 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-06-30 |
4 |
A |
$24.61 |
$999,967 |
I/I |
39,498 |
5,239,681 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-07-29 |
4 |
A |
$24.55 |
$999,967 |
I/I |
40,481 |
5,247,576 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-08-17 |
4 |
OE |
$2.65 |
$32,911 |
I/I |
11,828 |
5,259,404 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-08-31 |
4 |
A |
$25.24 |
$999,971 |
I/I |
35,509 |
5,267,327 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-09-30 |
4 |
A |
$27.44 |
$999,965 |
I/I |
36,291 |
5,274,464 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-10-31 |
4 |
A |
$26.10 |
$999,978 |
I/I |
37,647 |
5,282,126 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-11-30 |
4 |
A |
$29.18 |
$999,974 |
I/I |
31,348 |
5,288,980 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-12-13 |
4 |
B |
$28.90 |
$1,000,113 |
I/I |
34,606 |
213,805 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2016-12-30 |
4 |
A |
$24.30 |
$999,964 |
I/I |
36,418 |
5,297,210 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2017-01-31 |
4 |
A |
$21.16 |
$999,980 |
I/I |
41,748 |
5,306,661 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2017-03-31 |
4 |
A |
$19.82 |
$999,980 |
I/I |
47,897 |
5,325,535 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2017-04-28 |
4 |
A |
$19.67 |
$999,979 |
I/I |
50,267 |
5,335,131 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,135 |
3,552,388 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-05-11 |
4 |
OE |
$10.37 |
$103,700 |
D/D |
10,000 |
3,562,388 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2017-05-31 |
4 |
A |
$21.32 |
$999,961 |
I/I |
40,544 |
5,344,511 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-06-08 |
4 |
S |
$1.00 |
$1,975,000 |
I/I |
(1,975,000) |
786,613 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-06-29 |
4 |
A |
$0.00 |
$5,289,450 |
I/I |
359,785 |
27,651 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2017-06-30 |
4 |
A |
$22.82 |
$999,973 |
I/I |
43,358 |
5,352,813 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
4,592,086 |
2,327,603 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-07-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,328,853) |
0 |
0 |
- |
|
271 Records found
|
|
Page 6 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|